Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TS-161
DRUG
2 trials
Sponsors
Taisho Pharmaceutical R&D Inc.
, National Institute of Mental Health (NIMH)
Conditions
Depression
Healthy Volunteers
Major Depressive Disorder
Treatment-Resistant Depression
Phase 1
First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants
Completed
NCT03919409
Taisho Pharmaceutical R&D Inc.
Healthy Volunteers
Start: 2019-06-03
End: 2020-02-11
Updated: 2020-02-28
Phase 2
Antidepressant Effects of TS-161 in Treatment-Resistant Depression
Terminated
NCT04821271
National Institute of Mental Health (NIMH)
Depression, Major Depressive Disorder, Treatment-Resistant Depression
Start: 2021-06-10
End: 2024-05-23
Updated: 2025-06-10